Abstract
Cell culture models for gastrointestinal transport and metabolism are important mechanistic tools. Our studies of Caco-2 monolayers demonstrate heterogeneity in transport characteristics depending on passage number and origin of the cells. In accordance with data obtained in animals and humans, TRH shows a carrier-mediated, saturable transport component, which operates parallel to a passive pathway in Caco-2 cells at passage number 89-99. At low TRH concentrations (<3 mM) active transport becomes prominent, as demonstrated by the temperature dependence of TRH transport and inhibition experiments. The Michaelis-Menten parameters of the active, saturable transport component are: Km = 1.59 mM and Vmax = 1.84 µM/min. The pH optimum was determined to be at pH 6.0. On the other hand an exclusively paracellular passive route was found with Caco-2 cells at passage number 30-34. These results are also in agreement with observations made by others in cell culture experiments. The aspect of rigorously characterizing the specific Caco-2 clone under investigation is emphasized, especially when active transport mechanisms are suspected.
Similar content being viewed by others
REFERENCES
P. L. Smith, D. A. Wall, C. H. Gochoco and G. Wilson. (D) Routes of delivery: Case studies. (5) Oral absorption of peptides and proteins. Adv. Drug Delivery Rev. 8:253–290 (1992).
S. Yokohama, K. Yamashita, H. Toguchi, J. Takeuchi and N. Kitamori. Absorption of thyrotropin-releasing hormone after oral administration of TRH tartrate monohydrate in the rat, dog and human. J. Pharmacobio-Dyn. 7:101–111 (1984).
L. Duntas, F. S. Keck, U. Loos and E. F. Pfeiffer. Pharmakokinetik und Pharmakodynamik von Protirelin (TRH) beim Menschen. Dtsch. Med. Wschr. 113:1354–1357 (1988).
H. Bundgaard. (C) Means to enhance penetration. (1) Prodrugs as a mean to improve the delivery of peptide drugs. Adv. Drug Delivery Rev. 8:1–38 (1992).
S. Lundin, J. Moss, H. Bundgaard and P. Artursson. Absorption of thyrotropin-releasing hormone (TRH) and a TRH prodrug in a human intestinal cell line (Caco-2). Int. J. Pharm. 76:R1–R4 (1991).
D. T. Thwaites, B. H. Hirst and N. L. Simmons. Passive transepithelial absorption of thyrotropin-releasing hormone (TRH) via a paracellular route in cultured intestinal and renal epithelial cell lines. Pharm. Res. 10:674–681 (1993).
A. H. Dantzig and L. Bergin. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta 1027:211–217 (1990).
K. I. Inui, M. Yamamoto and H. Saito. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line. Caco-2: Specific transport systems in apical and basolateral membranes. J. Pharm. Exp. Ther. 261:195–201 (1992).
J. Moss, A. Buur and H. Bundgaard. Prodrugs of peptides. 8. In vitro study of intestinal metabolism and penetration of thyrotropin-releasing hormone (TRH) and its prodrugs. Int. J. Pharm. 66:183–191 (1990).
A. R. Hilgers, R. A. Conradi and P. S. Burton. Caco-2 cell monolayer as a model for drug transport across the intestinal mucosa. Pharm. Res. 9:902–910 (1990).
J. Moss and H. Bundgaard. Kinetics and pattern of degradation of thyrotropin-releasing hormone (TRH) in human plasma. Pharm. Res. 7:751–755 (1990).
R. Walter and T. Yoshimoto. Postproline cleaving enzyme: kinetic studies of size and stereospecificty of its active site. Biochemistry 17:4139–4144 (1978).
S. Wilk. Minireview prolyl endopeptidase. Life Sci 33:2149–57 (1983).
R. Wali, C. Baum, M. Sitrin and T. A. Brasitus. Regulation of protein kinase C, intracellular Ca2+ and Na+/H+ exchange in Caco-2 cells by 1,25(OH)2D3. Gastroenterology 96:A534 (1989).
C. J. Dix, H. Y. Orbay, I. F. Hassan and G. Wilson. Vitamin B12 transport through polarized monolayers of a colon carcinoma cell line. Biochem. Soc. Trans. 15:443–440 (1987).
A. Blais, P. Bissonnette and A. Berteloot. Common characteristics for Na-dependent sugar transport in Caco-2 cells and human fetal colon. J. Membr. Biol. 99:113–125 (1987).
M. Hu and R. T. Borchardt. Mechanism of L-methyldopa transport through a monolayer of polarized human epithelial cells (Caco-2). Pharm. Res. 7:1313–1319 (1990).
S. Yokohama, T. Yoshioka, K. Yamashita and N. Kitamori. Intestinal absorption mechanism of thyrotropin-releasing hormone. J. Pharmacobio-Dyn. 7:445–451 (1984).
M. Hu and R. T. Borchardt. Transport of a large neutral amino acid in a human intestinal epithelial cell line (Caco-2): Uptake and efflux of phenylalanine. Biochim. Biphys. Acta 1135:233–244 (1992).
M. Das and A. N. Radhakrishan. Studies on a wide-spectrum intestinal dipeptide uptake system in the monkeys and in the human. Biochem. J. 146:133–139 (1975).
V. Ganapathy and F. H. Leibach. Role of pH gradient and membrane potential in dipeptide transport in intestinal and renal brush-border membrane vesicles from the rabbit. Studies with L-carnosine and glycyl-L-proline. J. Biochem. Chem. 258:14189–14192 (1983).
D. I. Friedman and G. L. Amidon. Characterization of the intestinal transport parameters for small peptide drugs. J. Contr. Rel. 13:141–146 (1990).
M. Muranushi, T. Yoshikawa, M. Yoshida, T. Oguma, K. Hirano and H. Yamada. Transport characteristics of cefibuten, a new oral cephem, in rat intestinal brush-border membrane vesicles: Relationship to oligopeptide and amino β-lactam transport. Pharm. Res. 6:308–312 (1989).
S. A. Adibi and M. R. Soleimanpour. Functional characterization of dipeptide transport system in human jejunum. J. Clin. Invest. 53:1368–1374 (1974).
P. L. Nicklin and W. J. Irwin. Thyrotropin-releasing hormone transport across monolayers of human intestinal absorptive (Caco-2) cells in-vitro. J. Pharm. Pharmacol. 43:103P (1991).
T. Shimada and T. Hoshi, Na+-dependent elevation of the acidic cell surface pH (microclimate pH) of rat jejunal villus cells induced by nucleotides and phorbol ester: possible mediators of the regulation of the Na+/H+ antiporter. Biochim. Biophys. Acta 937:328–334 (1988).
M. L. Lucas, W. Schneider, F. J. Haberich and J. A. Blair. Direct measurement by pH-microelectrode of the pH microclimate in rat proximal jejunum. Proc. R. Soc. Lond. B. 192:39–48 (1975).
A. Zweibaum. Differentiation of human colon cancer cells. In G. Wilson, S. S. Davis, L. Illum, A. Zweibaum (eds.), Pharmaceutical applications of cell and tissue culture to drug transport, Plenum Press, New York and London, 1990, pp. 27–38.
S. Woodcock, I. Williamson, I. Hassan and M. Mackay. Isolation and characterization of clones from the Caco-2 cell line displaying increased taurocholic acid transport. J. Cell Sci. 98: 323–332 (1991).
P. Nicklin, B. Irwin, I. Hassan, I. Williamson and M. Mackay. Permeable support types influence the transport of compounds across Caco-2 cells. Int. J. Pharm. 83:197–209 (1992).
T. Sergent-Engelen, C. Halleux, E. Ferrain, H. Hanot, R. Legras and Y. J. Schneider. Improved cultivation of polarized animal cells on culture inserts with new transparent polyethylene terephthalate or polycarbonate microporous membranes. Biotechnology Techniques 4:89–94 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walter, E., Kissel, T. Transepithelial Transport and Metabolism of Thyrotropin-Releasing Hormone (TRH) in Monolayers of a Human Intestinal Cell Line (Caco-2): Evidence for an Active Transport Component?. Pharm Res 11, 1575–1580 (1994). https://doi.org/10.1023/A:1018953603301
Issue Date:
DOI: https://doi.org/10.1023/A:1018953603301